Gsa Capital Partners LLP Bioventus Inc. Transaction History
Gsa Capital Partners LLP
- $1.32 Billion
- Q3 2024
A detailed history of Gsa Capital Partners LLP transactions in Bioventus Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 58,832 shares of BVS stock, worth $628,325. This represents 0.05% of its overall portfolio holdings.
Number of Shares
58,832
Previous 31,700
85.59%
Holding current value
$628,325
Previous $182,000
286.26%
% of portfolio
0.05%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding BVS
# of Institutions
143Shares Held
45.9MCall Options Held
179KPut Options Held
124K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$139 Million44.65% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$74.1 Million33.68% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.35MShares$46.5 Million3.09% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$25.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.07MShares$22.1 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $659M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...